Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system

International Journal of Artificial Organs

Volumn 23, Issue 3, 2000, Pages 199-206

  Julius, U ^a   Siegert, G ^a   Gromeier, S ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Technischen Universität Dresden ^*

Author keywords

Anticoagulants; Blood coagulation; LDL apheresis

Indexed keywords

BLOOD; COAGULATION; GLYCOPROTEINS; MOLECULAR WEIGHT; PATIENT TREATMENT;

ANTI-COAGULATION; ANTICOAGULANT; BLOOD COAGULATION; BLOOD SAMPLES; COAGULATION SYSTEM; COAGULATION TESTS; FAMILIAL HYPERCHOLESTEROLEMIA; HIGH MOLECULAR WEIGHT; LDL APHERESIS; PATIENT'S SUFFERING;

LIPOPROTEINS;

ANTICOAGULANT AGENT; ANTITHROMBIN III; ATORVASTATIN; BICARBONATE; BLOOD CLOTTING FACTOR; COLLAGEN; FIBRINOGEN; HEPARIN; LOW DENSITY LIPOPROTEIN; LOW MOLECULAR WEIGHT KININOGEN; PREKALLIKREIN; PROTEIN S; PROTHROMBIN;

ADAPTATION; ADSORPTION; ADULT; AGED; APHERESIS; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DIALYSIS; DRUG INHIBITION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MALE; PRECIPITATION; PROTHROMBIN TIME; THROMBOPLASTIN TIME;

EID: 0033997057     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300309     Document Type: Article

References (25)

1. Park J-W, Merz M, Braun P. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia. Atherosclerosis 1998; 139: 401-9.
2. Schuff-Werner P, Gohlke H, Bartmann U, et al. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation. Eur J Clin Invest 1994; 24: 724-32.
3. Gordon BR, Stein E, Jones P, Illingworth DR. Indications for low-density lipoprotein apheresis. Am J Cardiol 1994; 74: 1109-12.
4. Mabuchi H, Koizumi J, Shimizu M, et al. For the Hokuriku-FH-LDL-Apheresis Study Group. Long-term efficacy of low density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Am J Cardiol 1998; 82: 1489-95.
5. Bosch T. Lipid apheresis: from a heroic treatment to routine clinical practice. Artif Organs 1996; 20: 414-9.
6. Thiery J, Seidel D. Safety and effectiveness of long-term LDL-apheresis in patients at high risk. Curr Opin Lipidol 1998; 9: 521-6.
7. Bosch T. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results. Artif Organs 1996; 20: 344-5.
8. Bosch T, Schmidt B, Kleophas W, et al. LDL hemoperfusion -a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood. Artif Organs 1997; 21: 977-82
9. Dräger LJ, Julius U, Kraenzle K, et al. DALI - the first human whole-blood low-density lipoprotein and lipoprotein(a) apheresis system in clinical use: procedure and clinical results. Eur J Clin Invest 1998; 28: 994-1002.
10. Derfler K, Druml W. A novel low-density lipoprotein device for removal of atherogenic lipoproteins from whole blood. Eur J Clin Invest 1998; 28: 1003-5.
11. Bosch T, Schmidt B, Blumenstein M, Gurland HJ. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood. Artif Organs 1993; 17: 640-52.
12. Bosch T, Schmidt B, Kleophas W, Otto V, Samtleben W. LDL hemoperfusion-a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients. Artif Organs 1997; 21: 1060-5.
13. Bosch T, Lennertz A, Kordes B, Santleben W. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis) clinical experience from a single center. Ther Apher 1999; 3: 209-13.
14. Grutzmacher P, Landgraf H, Esser R, et al. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation. ASAIO Trans 1990; 36: M327-30
15. Knisel W, Di Nicuolo A, Pfohl M, et al. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med 1993; 234: 479-87.
16. Lane DM, McConathy WJ, Laughlin LO, et al. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol 1993; 71: 816-22.
17. Pfalzer B, Beil F-U, Beisiegel U, Tilsner V, Greten H. Procoagulatory and fibrinolytic activities after LDL apheresis (HELP). In: Gotto AM, Mancini M, Richter WO, Schwandt P, eds. Treatment of Severe Hypercholesterolemia in the Prevention of Coronary Heart Disease. Basel: Karger, 1990; 234-42.
18. Schuff -Werner P, Schettler V. Plaquestabilisierung durch LDL-Apheresis. Herz 1999; 24: 57-61.
19. Schuff-Werner P, Seidel D. The H.E.L.P. system clinical experience of 10 years - a report. Jpn J Apheresis 1997; 16: 149-53.
20. Schaumann D, Welch-Wichary M, Voss A, Schmidt H, Olbricht CJ. Prospective cross-over comparisons of three low-density lipoprotein (LDL)-apheresis methods in patients with familial hypercholesterolaemia. Eur J Clin Invest 1996; 26: 1033-8.
21. Mannhalter C. Faktor XII: Biochemie, Molekularbiologie, Physiologie. In: Müller-Berghaus G, Pötzsch B, eds. Hämostaseologie - Molekular und zelluläre Mechanismen, Pathophysiologie und Klinik. Berlin, Heidelberg, New York, Barcelona, Budapest, Hongkong, London, Mailand, Paris, Singapur: Springer, 1999; 122-31.
22. Colman RW, Schmaler AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90: 3819-43.
23. Kojima S, Ogi M, Sugi T, Matsumoto Y, Yoshitomi Y, Kuramochi M. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis. Ther Apher 1997; 1: 356-61.
24. Kojima S, Harada-Shiba M, Yamamoto A. Plasma constituents other than low-density lipoprotein adsorbed by dextran-sulfate column (editorial). Ther Apher 1997; 1: 390-13.
25. Giansante C, Bordin P, Fiotti N, et al. Activation of coagulation by a LDL-apheresis device. Blood Coagul Fibrinolysis 1996; 7: 447-52.